Literature DB >> 34151902

Recent Developments in Diabetic Retinal Neurodegeneration: A Literature Review.

Shani Pillar1,2, Elad Moisseiev1,2, Jelizaveta Sokolovska3, Andrzej Grzybowski4,5.   

Abstract

Neurodegeneration plays a significant role in the complex pathology of diabetic retinopathy. Evidence suggests the onset of neurodegeneration occurs early on in the disease, and so a greater understanding of the process is essential for prompt detection and targeted therapies. Neurodegeneration is a common pathway of assorted processes, including activation of inflammatory pathways, reduction of neuroprotective factors, DNA damage, and apoptosis. Oxidative stress and formation of advanced glycation end products amplify these processes and are elevated in the setting of hyperglycemia, hyperlipidemia, and glucose variability. These key pathophysiologic mechanisms are discussed, as well as diagnostic modalities and novel therapeutic avenues, with an emphasis on recent discoveries. The aim of this article is to highlight the crucial role of neurodegeneration in diabetic retinopathy and to review the molecular basis for this neuronal dysfunction, its diagnostic features, and the progress currently made in relevant therapeutic interventions.
Copyright © 2020 Shani Pillar et al.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 34151902      PMCID: PMC7787838          DOI: 10.1155/2020/5728674

Source DB:  PubMed          Journal:  J Diabetes Res            Impact factor:   4.011


  159 in total

Review 1.  Retinal Neurodegeneration as an Early Manifestation of Diabetic Eye Disease and Potential Neuroprotective Therapies.

Authors:  Sidra Zafar; Mira Sachdeva; Benjamin J Frankfort; Roomasa Channa
Journal:  Curr Diab Rep       Date:  2019-02-26       Impact factor: 4.810

2.  Retinal ganglion cell neuroprotection by an angiotensin II blocker in an ex vivo retinal explant model.

Authors:  Andrew J R White; Janosch P Heller; Johahn Leung; Alessia Tassoni; Keith R Martin
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2015-01-26       Impact factor: 1.636

3.  A specific phosphorylation regulates the protective role of αA-crystallin in diabetes.

Authors:  Anne Ruebsam; Jennifer E Dulle; Angela M Myers; Dhananjay Sakrikar; Katelyn M Green; Naheed W Khan; Kevin Schey; Patrice E Fort
Journal:  JCI Insight       Date:  2018-02-22

Review 4.  Role of Oxidative Stress in Diabetic Retinopathy and the Beneficial Effects of Flavonoids.

Authors:  Mohammad Shamsul Ola; Dalia Al-Dosari; Abdullah S Alhomida
Journal:  Curr Pharm Des       Date:  2018       Impact factor: 3.116

5.  Glucose variability and inner retinal sensory neuropathy in persons with type 1 diabetes mellitus.

Authors:  M S Stem; G E Dunbar; G R Jackson; S Farsiu; R Pop-Busui; T W Gardner
Journal:  Eye (Lond)       Date:  2016-04-01       Impact factor: 3.775

6.  Reduced retinal vessel response to flicker stimulation but not to exogenous nitric oxide in type 1 diabetes.

Authors:  Berthold Pemp; Gerhard Garhofer; Günther Weigert; Katharina Karl; Hemma Resch; Michael Wolzt; Leopold Schmetterer
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-04-15       Impact factor: 4.799

7.  Up-Regulation Thioredoxin Inhibits Advanced Glycation End Products-Induced Neurodegeneration.

Authors:  Xiang Ren; Ni-Na Wang; Hui Qi; Yuan-Yuan Qiu; Cheng-Hong Zhang; Emily Brown; Hui Kong; Li Kong
Journal:  Cell Physiol Biochem       Date:  2018-11-01

8.  Association of Glycemic Variability in Type 1 Diabetes With Progression of Microvascular Outcomes in the Diabetes Control and Complications Trial.

Authors:  John M Lachin; Ionut Bebu; Richard M Bergenstal; Rodica Pop-Busui; F John Service; Bernard Zinman; David M Nathan
Journal:  Diabetes Care       Date:  2017-04-12       Impact factor: 19.112

9.  Effects of Liposomal Formulation of Citicoline in Experimental Diabetes-Induced Retinal Neurodegeneration.

Authors:  Patricia Bogdanov; Joel Sampedro; Cristina Solà-Adell; Olga Simó-Servat; Carla Russo; Luisa Varela-Sende; Rafael Simó; Cristina Hernández
Journal:  Int J Mol Sci       Date:  2018-08-20       Impact factor: 5.923

10.  Elucidating the mechanism of action of alpha-1-antitrypsin using retinal pigment epithelium cells exposed to high glucose. Potential use in diabetic retinopathy.

Authors:  María Constanza Potilinski; Gustavo A Ortíz; Juan P Salica; Emiliano S López; Mariano Fernández Acquier; Eduardo Chuluyan; Juan E Gallo
Journal:  PLoS One       Date:  2020-02-07       Impact factor: 3.240

View more
  2 in total

Review 1.  The pathophysiological mechanisms underlying diabetic retinopathy.

Authors:  Lindan Wei; Xin Sun; Chenxi Fan; Rongli Li; Shuanglong Zhou; Hongsong Yu
Journal:  Front Cell Dev Biol       Date:  2022-08-30

Review 2.  Vitreous Humor Proteome: Targeting Oxidative Stress, Inflammation, and Neurodegeneration in Vitreoretinal Diseases.

Authors:  Fátima Milhano Santos; Joana Mesquita; João Paulo Castro-de-Sousa; Sergio Ciordia; Alberto Paradela; Cândida Teixeira Tomaz
Journal:  Antioxidants (Basel)       Date:  2022-03-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.